Barely 24 hours after the World Health Organisation (WHO) suspended all clinical trials for hydroxychloroquine as a potential treatment for COVID-19, the National Agency for Food and Drug Administration and Control (NAFDAC) has said the trial will continue in Nigeria.
The UN agency had on Monday said it had 'temporarily' suspended the clinical trials of hydroxychloroquine as a potential treatment for COVID-19 over safety concerns.
Clinical trials in Nigeria
Mrs Adeyeye, however, said there are proven records that hydroxychloroquine has been effective in the treatment of COVID-19 patients.
"There is data to prove that hydroxychloroquine worked for many COVID-19 patients.
The governor said COVID-19 patients in the state would, henceforth, be treated with the drugs.
